Trial Profile
Efficacy of Eltrombopag in patients with refractory Aplastic Anaemia: a retrospective,single center analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association